date:Jul 19, 2012
ys the Commission should reject Chappells ruling and dismiss the FTCs complaint.
It adds: First, as [Chappell] recognized, RCTs simply are not required by the FTC Act to support health-benefit claims generally.
As for Chappells view that that POMs substantiation for some of its claims was incompetent and unreliable and thus misleading, this defies the evidence and flouts the First Amendment, claims POM.
It is undisputed that the studies on which[POM]relied were conducted by topflight research